Our findings demonstrate that the encapsulation of dBET6 within albumin nanoparticles coated with exosomes can significantly enhance the anti-tumor efficacy of dBET6, potentially addressing the therapeutic challenges associated with TNBC. This evidence concerns the gene ALB and neoplasm.